Stability of clinical condition in mild cognitive impairment is related to cortical sources of alpha rhythms: An electroencephalographic study

Human Brain Mapping

Volumn 32, Issue 11, 2011, Pages 1916-1931

  Babiloni, Claudio ^a,b   Frisoni, Giovanni B ^c   Vecchio, Fabrizio ^b   Lizio, Roberta ^d   Pievani, Michela ^c   Cristina, Geroldi ^c   Fracassi, Claudia ^c   Vernieri, Fabrizio ^e   Rodriguez, Guido ^f   Nobili, Flavio ^f   Ferri, Raffaele ^g   Rossini, Paolo M ^b,e  

^a UNIVERSITY OF FOGGIA   (Italy)

^b Casa di Cura San Raffaele Cassino ^*  (Italy)

^c IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^d IRCCS SAN RAFFAELE PISANA   (Italy)

^e UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^f UNIVERSITY OF GENOA   (Italy)

^g OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

Alpha rhythms; Alzheimer's disease; Cognitive decline; Electroencephalography; Low resolution brain electromagnetic tomography; Mild cognitive impairment

Indexed keywords

AGED; ALPHA RHYTHM; AMNESIA; ARTICLE; BETA RHYTHM; CEREBELLUM CORTEX; CLINICAL ARTICLE; CONTROLLED STUDY; DELTA RHYTHM; DISEASE ASSOCIATION; DISEASE COURSE; ELECTROENCEPHALOGRAPHY; EYE; FEMALE; FOLLOW UP; HUMAN; INFORMATION PROCESSING; LOW RESOLUTION BRAIN ELECTROMAGNETIC TOMOGRAPHY; MALE; MEMBRANE STEADY POTENTIAL; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL ANALYSIS; THETA RHYTHM;

AGED; ALPHA RHYTHM; ALZHEIMER DISEASE; COGNITION; CORTICAL SYNCHRONIZATION; DATA INTERPRETATION, STATISTICAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE PROGRESSION; ELECTROENCEPHALOGRAPHY; EXECUTIVE FUNCTION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS;

EID: 80053647862     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.21157     Document Type: Article

References (113)

1. Adler G, Brassen S, Jajcevic A (2003): EEG coherence in Alzheimer's dementia. J Neural Transm 110: 1051-1058.
2. Albert M, Smith LA, Scherr PA, Taylor JO, Evans DA, Funkenstein HH (1991): Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci 57: 167-178.
3. Altamura C, Squitti R, Pasqualetti P, Tibuzzi F, Silvestrini M, Ventriglia MC, Cassetta E, Rossini PM, Vernieri F. (2007): What is the relationship among atherosclerosis markers, apolipoprotein E polymorphism and dementia? Eur J Neurol 14: 679-682.
4. Arnaiz E, Almkvist O (2003): Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease. Acta Neurol Scand Suppl 179: 34-41.
5. Babiloni C, Binetti G, Cassetta E, Cerboneschi D, Dal Forno G, Del Percio C, Ferreri F, Ferri R, Lanuzza B, Miniussi C, Moretti DV, Nobili, Pascual-Marqui RD, Rodriguez G, Romani GL, Salinari S, Tecchio F, Vitali P, Zanetti O, Zappasodi F, Rossini PM; Mapping Distributed Sources of Cortical Rhythms in Mild Alzheimers Disease (2004): A multi-centric EEG study. NeuroImage 22: 57-67.
6. Babiloni C, Binetti G, Cassarino A, Dal Forno G, Del Percio C, Ferreri F, Ferri R, Frisoni G, Galderisi S, Hirata K, Lanuzza B, Miniussi C, Mucci A, Nobili F, Rodriguez G, Romani GL, Rossini PM (2006a): Sources of cortical rhythms in adults during physiological aging: A multi-centric EEG study. Human Brain Mapp 27: 162-172.
7. Babiloni C, Binetti G, Cassetta E, Dal Forno G, Del Percio C, Ferreri F, Ferri R, Frisoni G, Hirata K, Lanuzza B, Miniussi C, Moretti DV, Nobili F, Rodriguez G, Romani GL, Salinari S, Rossini PM (2006b): Sources of cortical rhythms change as a function of cognitive impairment in pathological aging: A multi-centric study. Clin Neurophysiol 117: 252-268.
8. Babiloni C, Benussi L, Binetti G, Bosco P, Busonero G, Cesaretti S, Dal Forno G, Del Percio C, Ferri R, Frisoni G, Ghidoni R, Rodriguez G, Squitti R, Rossini PM (2006c): Genotype (cystatin C) and EEG phenotype in Alzheimer disease and mild cognitive impairment: A multicentric study. Neuroimage 29: 948-964.
9. Babiloni C, Benussi L, Binetti G, Cassetta E, Dal Forno G, Del Percio C, Ferreri F, Ferri R, Frisoni G, Ghidoni R, Miniussi C, Rodriguez G, Romani GL, Squitti R, Ventriglia MC, Rossini PM (2006d): Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: A multicentric EEG study. Ann Neurol 59: 323-334.
10. Babiloni C, Frisoni G, Steriade M, Bresciani L, Binetti G, Del Percio C, Geroldi C, Miniussi C, Nobili F, Rodriguez G, Zappasodi F, Carfagna T, Rossini PM (2006e): Frontal white matter volume and delta EEG sources negatively correlate in awake subjects with mild cognitive impairment and Alzheimer's disease. Clin Neurophysiol 117: 1113-1129.
11. Babiloni C, Cassetta E, Dal Forno G, Del Percio C, Ferreri F, Ferri R, Lanuzza B, Miniussi C, Moretti DV, Nobili FF, Pascual-Marqui RD, Rodriguez G, Romani GL, Salinari S, Zanetti O, Rossini PM (2006f): Donepezil effects on sources of cortical rhythms in mild Alzheimer's disease: Responders vs. non-responders. Neuroimage 31: 1650-1665.
12. Babiloni C, Cassetta E, Binetti G, Tombini M, Del Percio C, Ferreri F, Ferri R, Frisoni G, Lanuzza B, Nobili F, Parisi L, Rodriguez G, Frigerio L, Gurzì M, Prestia A, Vernieri F, Eusebi F, Rossini PM (2007): Resting EEG sources correlate with attentional span in mild cognitive impairment and Alzheimer's disease. Eur J Neurosci 25: 3742-3757.
13. Babiloni C, Pievani M, Vecchio F, Geroldi C, Eusebi F, Fracassi C, Fletcher E, De Carli C, Boccardi M, Rossini PM, Frisoni GB (2009): White-matter lesions along the cholinergic tracts are related to cortical sources of EEG rhythms in amnesic mild cognitive impairment. Hum Brain Mapp.
14. Babiloni C, Visser PJ, Frisoni G, De Deyn PP, Bresciani L, Jelic V, Nagels G, Rodriguez G, Rossini PM, Vecchio F, Colombo D, Verhey F, Wahlund LO, Nobili F (2010): Cortical sources of resting EEG rhythms in mild cognitive impairment and subjective memory complaint. Neurobiol Aging 31: 1787-1798.
15. Bachman DL, Wolf PA, Linn RT, Knoefel JE, Cobb JL, Belanger AJ, White LR, D'Agostino RB (1993): Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham study. Neurology 43( 3 Pt 1): 515-519.
16. Becker R (2001): Modifying clinical trial designs to test treatments for clinical significance in individual patients. Clin Drug Invest 21: 727-733.
17. Becker R, Markwell S (2000): Problems arising from the generalising of treatment efficacy from clinical trials in Alzheimer's disease: Mistaking statistical significance as clinical significance. Clin Drug Invest 19: 33-41.
18. Bennett DA, Wilson RS, Schneider JA, Evans DA, Beckett LA, Aggarwal NT, Barnes LL, Fox JH, Bach J (2002): Natural history of mild cognitive impairment in older persons. Neurology 59: 198-205.
19. Carlesimo GA, Caltagirone C, Gainotti G, and the Group for the Standardization of the Mental Deterioration Battery (1996): The Mental Deterioration Battery: Normative data, diagnostic reliability and qualitative analyses of cognitive impairment. Eur Neurol 36: 378-384.
20. Chandler MJ, Lacritz LH, Cicerello AR, Chapman SB, Honig LS, Weiner MF, Cullum CM (2004): Three-word recall in normal aging. J Clin Exp Neuropsychol 26: 1128-1133.
21. Claassen JA, Jansen RW (2006): Cholinergically mediated augmentation of cerebral perfusion in Alzheimer's disease and related cognitive disorders: The cholinergic-vascular hypothesis. J Gerontol Ser A, Biol Sci Med Sci 61: 267-271.
22. de Jong LW, van der Hiele K, Veer IM, Houwing JJ, Westendorp RG, Bollen EL, de Bruin PW, Middelkoop HA, van Buchem MA, van der Grond J (2008): Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: An MRI study. Brain 131( Pt 12): 3277-3285.
23. De Renzi E, Vignolo LA (1962): The token test: A sensitive test to detect receptive disturbances in aphasics. Brain 85: 665-678.
24. Devanand DP, Folz M, Gorlyn M, Moeller JR, Stem J (1997): Questionable dementia: Clinical course and predictors of outcome. J Am Geriatr Soc 45: 321-328.
25. Dierks T, Ihl R, Frolich L, Maurer K (1993): Dementia of the Alzheimer type: Effects on the spontaneous EEG described by dipole sources. Psychiatry Res 50: 151-162.
26. Dierks T, Jelic V, Pascual-Marqui RD, Wahlund LO, Julin P, Linden DEJ, Maurer K, Winblad B, Nordberg A (2000): Spatial pattern of cerebral glucose metabolism (PET) correlates with localization of intracerebral EEG-generators in Alzheimer's disease. Clin Neurophysiol 111: 1817-1824.
27. Di Lazzaro V, Oliviero A, Pilato F, Saturno E, Dileone M, Marra C, Daniele A, Ghirlanda S, Gainotti G, Tonali PA (2004): Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease. J Neurol Neurosurg Psychiatry 75; 555-559.
28. Dringenberg HC (2000): Alzheimer's disease: More than a 'cholinergic disorder'-Evidence that cholinergic-monoaminergic interactions contribute to EEG slowing and dementia. Behav Brain Res 115: 235-249.
29. Elmstahl S, Rosen I (1997): Postural hypotension and EEG variables predict cognitive decline: Results from a 5-year follow-up of healthy elderly women. Dement Geriatr Cogn Disord 8: 180-187.
30. Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD (1999): Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 354: 919-920.
31. Etiene D, Kraft J, Ganju N, Gomez-Isla T, Gemelli B, Hyman BT, Hedley-Whyte ET, Wands JR, De La Monte SM. (1998): Cerebrovascular pathology contributes to the heterogeneity of Alzheimer's disease. J Alzheimers Dis 1: 119-134.
32. Fisk JD, Merry HR, Rockwood K (2003): Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology 61: 1179-1184.
33. Flicker CS, Ferris H, Reisberg B (1991): Mild cognitive impairment in the elderly: Predictors of dementia. Neurology 41: 1006-1009.
34. Folstein MF, Folstein SE, McHugh PR (1975): 'Mini Mental State': A practical method for grading the cognitive state of patients for clinician. J Psychiatr Res 12: 189-198.
35. Frisoni GB, Padovani A, Wahlund LO (2004): The predementia diagnosis of Alzheimer disease. Alzheimer Dis Assoc Disord 18: 51-53.
36. Galluzzi S, Cimaschi L, Ferrucci L, Frisoni GB (2001): Mild cognitive impairment: Clinical features and review of screening instruments. Aging (Milano) 13: 183-202.
37. Gao S, Hendrie HC, Hall KS, Hui S (1998): The relationships between age, sex, and the incidence of dementia and Alzheimer disease: A meta-analysis. Arch Gen Psychiatry 55: 809-815.
38. Geula C, Mesulam MM (1989): Cortical cholinerigc fibers in aging and Alzheimer's disease: A morphometirc study. Neuroscience 33: 469-481.
39. Geula C, Mesulam MM (1996): Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease. Cereb Cortex 6: 165-177.
40. Geula C, Mesulam MM (1999): Cholinergic system in Alzheimer's disease. In: Terry RD, Katzman R, Bick KL, Sisodia SS, editors. Alzheimer Disease, 2nd ed. Philadelphia, PA: Lippincot, Williams & Wilkins. pp 269-292.
41. Helkala EL, Hanninen T, Hallikainen M, Kononen M, Laakso MP, Hartikainen P, Soininen H, Partanen J, Partanen K, Vainio P, Riekkinen PSr (1996): Slow-wave activity in the spectral analysis of the electroencephalogram and volumes of hippocampus in subgroups of Alzheimer's disease patients. Behav Neurosci 110: 1235-1243.
42. Heyman A, Fillenbaum GG, Welsh-Bohmer KA, Gearing M, Mirra SS, Mohs RC, Peterson BL, Pieper CF. (1998): Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to establish a registry for Alzheimer's disease. Neurology 51: 159-162 [Erratum: Neurology 1998;51:1809].
43. Holschneider DP, Waite JJ, Leuchter AF, Walton NY, Scremin OU (1999): Changes in electrocortical power and coherence in response to the selective cholinergic immunotoxin 192 IgG-saporin. Exp Brain Res 126: 270-280.
44. Huang C, Wahlund LO, Dierks T, Julin P, Winblad B, Jelic V (2000): Discrimination of Alzheimer's disease and mild cognitive impairment by equivalent EEG sources: A cross-sectional and logitudinal study. Clin Neurophysiol 11: 1961-1967.
45. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL (1982): A new clinical scale for the staging of dementia. Br J Psychiatry 140: 566-572.
46. Jack CR Jr, Shiung MM, Weigand SD, O'Brien PC, Gunter JL, Boeve BF, Knopman DS, Smith GE, Ivnik RJ, Tangalos EG, Petersen RC (2005): Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 65: 1227-1231.
47. Jelic V, Johansson SE, Almkvist O, Shigeta M, Julin P, Nordberg A, Winblad B, Wahlund LO (2000): Quantitative electroencephalography in mild cognitive impairment: Longitudinal changes and possible prediction of Alzheimer's disease. Neurobiol Aging 21: 533-540.
48. Jellinger KA (2001): Small concomitant cerebrovascular lesions are not important for cognitive decline in severe Alzheimer disease (letter). Arch Neurol 58: 520-521.
49. Jellinger KA, Mitter-Ferstl E (2003): The impact of cerebrovascular lesions in Alzheimer disease-A comparative autopsy study. J Neurol 250: 1050-1055.
50. Jeong J (2004): EEG dynamics in patients with Alzheimer's disease. Clin Neurophysiol 115: 1490-1505.
51. Klimesch W (1996): Memory processes, brain oscillations and EEG synchronization. Int J Psychophysiol 24: 61-100.
52. Klimesch W, Doppelmayr M, Pachinger T, Russegger H (1997): Event-related desynchronization in the alpha band and the processing of semantic information. Brain Res Cogn Brain Res 6: 83-94.
53. Klimesch W, Doppelmayr M, Russegger H, Pachinger T, Schwaiger J (1998): Induced alpha band power changes in the human EEG and attention. Neurosci Lett 244: 73-76.
54. Klimesch W (1999): EEG alpha and theta oscillations reflect cognitive and memory performance: A review and analysis. Brain Res Rev 29: 169-195.
55. Knopman DS, Boeve BF, Parisi JE, Dickson DW, Smith GE, Ivnik RJ, Josephs KA, Petersen RC (2005): Antemortem diagnosis of frontotemporal lobar degeneration. Ann Neurol 57: 480-488.
56. Koenig T, Prichep L, Dierks T, Hubl D, Wahlund LO, John ER, Jelic V (2005): Decreased EEG synchronization in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 26: 165-171.
57. Larrieu S, Letenneur L, Orgogozo JM, Fabrigoule C, Amieva H, Le Carret N, Barberger-Gateau P, Dartigues JF (2002): Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 59: 1594-1599.
58. Lawton MP, Brodie EM (1969): Assessment of older people: Self maintaining and instrumental activity of daily living. J Gerontol 9: 179-186.
59. Lee JH, Olichney JM, Hansen LA, Hofstetter CR, Thal LJ (2000): Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch Neurol 57: 1474-1479.
60. Leuchter AF, Cook IA, Newton TF, Dunkin J, Walter DO, Tompson SR, Lachenbruch PA, Weiner H (1993): Regional differences in brain electrical activity in dementia: Use of spectral power and spectral ratio measures. Electroenceph Clin Neurophysiol 87: 385-393.
61. Mash DC, Flynn DD, Potter LT (1985): Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 228: 1115-1117.
62. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, Costa D, Del Ser T, Dubois B, Galasko D, Gauthier S, Goetz CG, Gomez-Tortosa E, Halliday G, Hansen LA, Hardy J, Iwatsubo T, Kalaria RN, Kaufer D, Kenny RA, Korczyn A, Kosaka K, Lee VM, Lees A, Litvan I, Londos E, Lopez OL, Minoshima S, Mizuno Y, Molina JA, Mukaetova-Ladinska EB, Pasquier F, Perry RH, Schulz JB, Trojanowski JQ, Yamada M; Consortium on DLB (2005): Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology 65: 1863-1872.
63. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984): Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34: 939-944.
64. Mesulam M, Shaw P, Mash D, Weintraub S (2004): Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol 55: 815-828.
65. Moretti DV, Babiloni F, Carducci F, Cincotti F, Remondini E, Rossini PM, Salinari S, Babiloni C (2003): Computerized processing of EEG-EOG-EMG artifacts for multicentirc studies in EEG oscillations and event-related potentials. Int J Pshycophysiol 47: 199-216.
66. Mungas D, Reed BR, Ellis WG, Jagust WJ (2001): The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease. Arch Neurol 58: 1243-1247.
67. Nagy Z, Esiri MM, Jobst KA, Morris JH, King EM-F, McDonald B, Joachim C, Litchfield S, Barnetson L, Smith AD. (1997): The effects of additional pathology on the cognitive deficit in Alzheimer disease. J Neuropathol Exp Neurol 56: 165-170.
68. Novelli G (1986): Three clinical tests for the assessment of lexical retrieval and production. Norms from 320 normal subjects. Arch Psicol Neurol Psichiatr 47: 477-506.
69. Nuwer MR (1988): Quantitative EEG. I. Tecniques and problems of frequency analysis and topographic mapping. J Clin Neurophysiol 5: 1-43.
70. Orsini A, Grossi D, Capitani E, Laiacona M, Papagno C, Vallar G (1987): Verbal and spatial immediate memory span: Normative data from 1355 adults and 1112 children. Ital J Neurol Sci 8: 539-548.
71. Osipova D, Ahveninen J, Kaakkola S, Jaaskelainen IP, Huttunen J, Pekkonen E (2003): Effects of scopolamine on MEG spectral power and coherence in elderly subjects. Clin Neurophysiol 114: 1902-1907.
72. Pascual-Marqui RD, Michel CM (1994): LORETA (low resolution brain electromagnetic tomography): New authentic 3D functional images of the brain. ISBET Newslett ISSN 5: 4-8.
73. Pascual-Marqui RD, Lehmann D, Koenig T, Kochi K, Merlo MC, Hell D, Koukkou M (1999): Low resolution brain electromagnetic tomography (LORETA) functional imaging in acute, neuroleptic-naive, first-episode, productive schizophrenia. Psychiatry Res 90: 169-179.
74. Pascual-Marqui RD, Esslen M, Kochi K, Lehmann D (2002): Functional imaging with low resolution brain electromagnetic tomography (LORETA): A review. Methods Find Exp Clin Pharm 91-95.
75. Petersen RC (2004): Mild cognitive impairment as a diagnostic entity. J Intern Med 256: 183-194.
76. Petersen RC, Smith GE, Ivnik RJ, Tangalos EG, Schaid SN, Thibodeau SN, Kokmen E, Waring SC, Kurland LT (1995): Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 273: 1274-1278.
77. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Kokmen E, Tangelos EG (1997): Aging, memory, and mild cognitive impairment. Int Psychogeriatr (9 Suppl 1): 65-69.
78. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B (2001): Current concepts in mild cognitive impairment. Arch Neurol 58: 1985-1992.
79. Ponomareva NV, Selesneva ND, Jarikov GA (2003): EEG alterations in subjects at high familial risk for Alzheimer's disease. Neuropsychobiology 48: 152-159.
80. Portet F, Ousset PJ, Visser PJ, Frisoni GB, Nobili F, Scheltens P, Vellas B, Touchon J; MCI Working Group of the European Consortium on Alzheimer's Disease (2006): Mild cognitive impairment (MCI) in medical practice: A critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's disease. J Neurol Neurosurg Psychiatry 77: 714-718.
81. Koenig T, Prichep L, Dierks T, Hubl D, Wahlund LO, John ER, Jelic V. (2005): Decreased EEG synchronization in Alzheimer's disease and mild cognitive impairment. Neurobiol Aging 26: 165-171.
82. Prichep LS, John ER, Ferris SH, Rausch L, Fang Z, Cancro R, Torossian C, Reisberg B (2006): Prediction of longitudinal cognitive decline in normal elderly with subjective complaints using electrophysiological imaging. Neurobiol Aging 27: 471-481.
83. Raven (1965): Guide to Using Coloured Progressive Matrices. London, UK: K Lewis.
84. Reitan RM. (1958): Validity of the Trail Making Test as an indication of organic brain damage. Percept Motor Skill1958: 271-276.
85. Rey A (1958): Memorisation d'une serie de 15 mots en 5 repetitions. In: Rey A, editor. L'Examen Clinique en Psychologie. Paris: Presses Universitaires de France.
86. Rey A (1968): Reattivo Della Figura Complessa Manuale. Firenze: Organizzazioni Speciali.
87. Ricceri L, Minghetti L, Moles A, Popoli P, Confaloni A, De Simone R, Piscopo P, Scattoni ML, di Luca M, Calamandrei G (2004): Cognitive and neurological deficits induced by early and prolonged basal forebrain cholinergic hypofunction in rats. Exp Neurol 189: 162-172.
88. Rodriguez G, Nobili F, Rocca G, DeCarli F, Gianelli MV, Rosadini G (1998): Quantitative electroencephalography and regional cerebral blood flow: Discriminant analysis between Alzheimer's patients and healthy controls. Dementia Geriatric Cognitive Disorder 9: 238-274.
89. Rodriguez G, Copello F, Nobili F, Vitali P, Perego G, Nobili F (1999a): EEG spectral profile to stage Alzheimer's disease. Clin Neurophysiol 110: 1831-1837.
90. Rodriguez G, Nobili F, Copello F, Vitali P, Gianelli MV, Taddei G, Catsafados E, Mariani G. (1999b): 99mTc-HMPAO regional cerebral blood flow and quantitative electroencephalography in Alzheimer's disease: A correlative study. J Nucl Med 40: 522-529.
91. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P. (1993): Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43: 250-260.
92. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A (1980): Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 7: 486-488.
93. Rossini PM, Desiato MT, Lavaroni F, Caramia MD (1991): Brain excitability and electroencephalographic activation: Non-invasive evaluation in healthy humans via transcranial magnetic stimulation. Brain Res 567: 111-119.
94. Rossini PM, Del Percio C, Pasqualetti P, Cassetta E, Binetti G, Dal Forno G, Ferreri F, Frisoni G, Chiovenda P, Miniussi C, Parisi L, Tombini M, Vecchio F, Babiloni C (2006): Conversion from mild cognitive impairment to Alzheimer's disease is predicted by sources and coherence of brain electroencephalography rhythms. Neuroscience 143: 793-803.
95. Rossini PM, Rossi S, Babiloni C, Polich J (2007): Clinical neurophysiology of aging brain: From normal aging to neurodegeneration. Prog Neurobiol 83: 375-400.
96. Rubin EH, Morris JC, Grant EA, Vendegna T (1989): Very mild senile dementia of the Alzheimer type. I. Clinical assessment. Arch Neurol 46: 379-382.
97. Scheltens P, Fox N, Barkhof F, De Carli C (2002): Structural magnetic resonance imaging in the practical assessment of dementia: Beyond exclusion. Lancet Neurol 1: 13-21.
98. Shulman KI, Gold DP, Cohen CA, Zucchero CA (1993): Clock drawing and dementia in thecommunity: A longitudinal study. Int J Geriatr Psychiatr 8: 487-496.
99. Silvestrini M, Pasqualetti P, Baruffaldi R, Bartolini M, Handouk Y, Matteis M, Moffa F, Provinciali L, Vernieri F. (2006): Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease. Stroke 37: 1010-1015.
100. Sloan EP, Fenton GW, Kennedy NSJ, MacLennan JM (1995): Electroencephalography and single photon emission computed tomography in dementia: A comparative study. Psychol Med 25: 631-638.
101. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997): Brain infarction and the clinical expression of Alzheimer disease. The Nun study. JAMA 277: 813-817.
102. Spinnler H, Tognoni G (1987): Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci 1987; (Suppl 6): 8.
103. Steriade M, Llinas RR (1988): The functional states of the thalamus and the associated neuronal interplay. Physiol Rev 68: 649-742.
104. Talairach J, Tournoux P (1988): Co-Planar Stereotaxic Atlas of the Human Brain. Stuttgart: Thieme.
105. Tanaka Y, Hanyu H, Sakurai H, Takasaki M, Abe K (2003): Atrophy of the substantia innominata on magnetic resonance imaging predicts response to donepezil treatment in Alzheimer's disease patients. Dement Geriatr Cogn Disord 16: 119-125.
106. Teipel SJ, Flatz WH, Heinsen H, Bokde AL, Schoenberg SO, Stockel S, Dietrich O, Reiser MF, Moller HJ, Hampel H (2005): Measurement of basal forebrain atrophy in Alzheimer's disease using MRI. Brain 128( Pt 11): 2626-2644.
107. Tombaugh TN (2005): Test-retest reliable coefficients and 5-year change scores for the MMSE and 3MS. Arch Clin Neuropsychol 20: 485-503.
108. Valdès P, Picton TW, Trujillo N, Bosch J, Aubert E, Riera J (1998): Constraining EEG-MEG source imaging with statistical neuroanatomy. Neuroimage 4: 635.
109. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO (1982-1983): Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 17: 37-49.
110. Zappoli R, Versari A, Paganini M, Arnetoli G, Muscas GC, Gangemi PF, Arneodo MG, Poggiolini D, Zappoli F, Battaglia A (1995): Brain electrical activity (quantitative EEG and bit-mapping neurocognitive CNV components), psychometrics and clinical findings in presenile subjects with initial mild cognitive decline or probable Alzheimer-type dementia. Ital J Neurol Sci 16: 341-376.
111. Zaudig M (1992): A new systematic method of measurement and diagnosis of "mild cognitive impairment" and dementia according to ICD-10 and DSM-III-R criteria. Int Psychogeriatr 4 (Suppl 2): 203-219.
112. Zekry D, Duyckaerts C, Moulias R, Belmin J, Geoffre C, Herrmann F, Hauw JJ. (2002): Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly, Acta Neuropathol (Berl) 103: 481-487.
113. Zekry D, Duyckaerts C, Belmin J, Geoffre C, Herrmann F, Moulias R, Hauw JJ. (2003): The vascular lesions in vascular and mixed dementia: The weight of functional neuroanatomy, Neurobiol Aging 24: 213-219.